Roquette Frères S.A. entered into a definitive agreement to acquire Pharma Solutions Business of International Flavors & Fragrances Inc. (NYSE:IFF) for an enterprise value of approximately $2.9 billion on March 19, 2024. As per the agreement which is for an enterprise value of up to $2.85 billion, which represents an enterprise value to EBITDA multiple of approximately 13x. Pharma Solutions operates 10 research and development and/or production sites globally, with approximately 1100 employees, and generated approximately $1 billion revenue in 2023.

IFF and Roquette expect to close the transaction in the first half of 2025, subject to applicable information and/or consultation requirements and customary closing conditions, including regulatory approvals. J.P. Morgan Securities LLC acted as exclusive financial advisor to IFF, Skadden, Arps, Slate, Meagher & Flom LLP acted as counsel, and Evercore as advisor to the board. Cleary Gottlieb Steen & Hamilton LLP is representing Roquette in the transaction.